Monsanto continued to post weak results for fiscal 2010 with an EPS of $2.41, almost half its $4.41 in fiscal 2009 due to the decrease in the prices of Roundup herbicides. The increase in cost and expense was the icing on the cake.
Further, a slower market recovery and an intensely competitive environment posts additional challenges for the company. Thus, our Underperform recommendation on the stock indicates that it would perform below the broader market. Our $53.00 target price, 18.9x 2011 EPS, reflects this view.
MONSANTO CO-NEW (MON): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.